Knockdown of PC4 increases chemosensitivity of Oxaliplatin in triple negative breast cancer by suppressing mTOR pathway.
Wang Q, Ma L, Chen L, Chen H, Luo M, Yang W, Liao F, Gong Q, Wang Y, Yang Z, et al. Biochem Biophys Res Commun. 2021 Mar 12; 544:65-72. Epub 2021 Jan 29.